Genotypic Technology Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 2.58 M
- Company Age 26 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.90 Cr
- Satisfied Charges ₹ 3.66 M
- Revenue Growth 60.48%
- Profit Growth 62.34%
- Ebitda 47.22%
- Net Worth 44.48%
- Total Assets 29.85%
About Genotypic Technology
Genotypic Technology Private Limited (GTPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 09 October 1998 and has a history of 26 years and three months. Its registered office is in Bangalore, Karnataka, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.58 M.
The company currently has active open charges totaling ₹6.90 Cr. The company has closed loans amounting to ₹3.66 M, as per Ministry of Corporate Affairs (MCA) records.
Sudha Rao and Raja Mugasimangalam serve as directors at the Company.
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U72200KA1998PTC049038
- Company No.
049038
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Oct 1998
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
What products or services does Genotypic Technology Private Limited offer?
Genotypic Technology Private Limited offers a wide range of products and services, including Data Entry & Data Processing Service, Data Management, Medical Laboratory Instruments, Corona Test Kit, Diagnostic Imaging & Pathology Labs, Medical Test Services, Inspection & Quality Check Services, Quality Inspection Service.
Who are the key members and board of directors at Genotypic Technology?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raja Mugasimangalam  | Managing Director | 09-Oct-1998 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sudha Rao | Whole-Time Director | 29-Sep-1999 | Current |
Financial Performance of Genotypic Technology.
Genotypic Technology Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 60.48% increase. The company also saw a substantial improvement in profitability, with a 62.34% increase in profit. The company's net worth Soared by an impressive increase of 44.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genotypic Technology?
In 2023, Genotypic Technology had a promoter holding of 70.52% and a public holding of 29.48%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Qtlomics Technologies Private LimitedRaja Mugasimangalam is a mutual person
Dhiti Omics Technologies Private LimitedSudha Rao is a mutual person
Bangalore Bioinnovation CentreSudha Rao is a mutual person
Charges (Loans)
₹69.04 M
₹3.66 M
Charges Breakdown by Lending Institutions
- Canara Bank : 5.36 Cr
- Siemens Financial Services Private Limited : 1.40 Cr
- Hdfc Bank Limited : 0.14 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Mar 2022 | Hdfc Bank Limited | ₹1.41 M | Open |
| 30 May 2014 | Siemens Financial Services Private Limited | ₹1.40 Cr | Open |
| 14 Dec 2012 | Canara Bank | ₹1.13 M | Open |
| 19 Jul 2008 | Canara Bank | ₹5.25 Cr | Open |
| 30 Mar 2009 | Canara Bank | ₹0.29 M | Satisfied |
How Many Employees Work at Genotypic Technology?
Genotypic Technology has a workforce of 82 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genotypic Technology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genotypic Technology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
